$AXON

SMITH PATRICK W sold $10.0M of AXON

SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) sold 20,000 shares of AXON ENTERPRISE, INC. (AXON) at $500.00 ($10.00M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SMITH PATRICK W
Published Jun 8, 2026, 8:54 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

A $10M CEO sale can create short-lived negative sentiment, but the pre-arranged 10b5-1 structure suggests the timing was predetermined.

02

Market read

Primarily a sentiment/positioning datapoint for AXON; no new business or financial guidance is provided.

03

What to watch

Traders may over-weight insider sales; without accompanying operational/regulatory updates, the filing is unlikely to change valuation drivers.

Relevance 6/10Novelty 8/10Timing: Filed June 8; sale executed June 4.

Background

The article is an SEC Form 4 insider transaction disclosure (open-market sale) by Axon’s CEO.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon CEO Patrick W. Smith filed an open-market sale of 20,000 shares for $10.0M under a pre-arranged 10b5-1 plan.

Expected impact

Near-term impact likely limited; any reaction may be muted because the sale is planned rather than discretionary.

Evidence & confidence

Form 4 discloses a material dollar amount ($10M) and the seller is the CEO, but the presence of a pre-arranged 10b5-1 plan typically lowers interpretive value for fundamentals.

Market effects

Minimal—this is company-specific insider transaction disclosure, not a sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • AXON ENTERPRISE, INC.

    Company whose shares were sold by its CEO under a 10b5-1 plan.

  • SMITH PATRICK W

    Chief Executive Officer and director who sold 20,000 shares.

Related articles

$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

$AXONMedAI 8/10

Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?

Axon Enterprise (AXON) reported Q2 revenue of $904 million, up 35% year over year, versus $876.5 million expected, with TASER revenue up 21% to $261.3 million. Adjusted EBITDA rose 40% to $242 million and adjusted EPS was $1.88. The company raised full-year revenue guidance to 32%-34% growth and maintained 25.5% adjusted EBITDA margin, but the stock fell after hours and during the session.

$AXONMed

Axon Enterprise Stock Slips After Q2 Earnings - Axon Enterprise (NASDAQ:AXON)

Axon Enterprise reported Q2 revenue of $904.39 million, above the $876.46 million estimate, and adjusted EPS of $1.88, above $1.85, according to Benzinga Pro. Software and Services revenue rose to $398 million and Connected Devices to $507 million. Annual recurring revenue increased to $1.6 billion. The company raised 2026 guidance to $3.67-$3.73 billion. Shares fell 6.32% after hours to $570.95.

$AXONMed

Axon posts lower quarterly gross margin on higher mix of services, new product scaling

Axon Enterprise reported lower Q2 gross margin, citing a higher mix of professional services and spending to scale new product offerings, according to Reuters. Adjusted gross margin in its software and services segment fell 3.8 points to 75.1%. Revenue rose to $904 million, above $877 million estimates, and adjusted EPS was $1.88 vs $1.85 expected. Shares fell over 6% after hours.

$AXONHighAI 9/10

AXON ENTERPRISE, INC. (AXON): Results of Operations and Financial Condition

AXON ENTERPRISE, INC. (AXON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 axon-20260805xex991.htm EX-99.1 Document Exhibit 99.1 CONTACT: Investor Relations Axon Enterprise, Inc. IR@axon.com Axon reports Q2 2026 revenue of $904 million, up 35% year over year • Annual recurring revenue grows 39% to $1.6 billion; net revenue retention reaches 12